Jakub Swiercz

VP R&D at Alesta Therapeutics

Charleroi Metropolitan Area

About

Seasoned project leader with more than ten years of relevant experience leading interdisciplinary projects in biotech and academia. Expertise in the drug discovery in the fields of Oncology and Immuno-Oncology. Proven interpersonal skills and experience in leading cross-functional teams.

Experience

  • VP R&D at Alesta Therapeutics
    Jun 2021 - Present · 5 yrs 1 mo

    Leveraging cancer metabolism for patient benefits.

  • Managing Director at JakOnco
    May 2021 - Present · 5 yrs 2 mos

  • Head of Cancer Biology at EPICS Therapeutics
    Sep 2019 - May 2021 · 1 yr 9 mos

  • Head of In Vitro Pharmacology & Screening at iTeos Therapeutics SA
    Jul 2015 - Aug 2019 · 4 yrs 2 mos

    • Leader of the In Vitro Pharmacology. Directing research aimed at target identification, validation and characterizing mechanisms of action of new therapeutics • Project Leader and developer of iTeos target discovery platform dedicated to the identification of novel immuno-oncology targets • Project Leader in immuno-oncology and oncology; from target validation to early clinical development in a matrix organization. Definition, validation, implementation, and management of projects objectives, milestones, budgets, staff, and resources. Responsible for program visibility and presentation on scientific and business level • Coordination and oversight of collaborations with academic and industrial partners

  • Project Leader at Max Planck Institute for Heart and Lung Research
    Sep 2009 - Jun 2015 · 5 yrs 10 mos

    • Led the team responsible for identification and development of anti-Plexin-B1 monoclonal antibodies with therapeutic potential o Managed in house work and collaboration with biotech partners interested in antibody commercialization • Managed collaboration with biotech company on co-development of small molecule inhibitor of Plexin-Semaphorin signalling